BIOLASE Announces Appointment of William E. Brown to Vice President, Sales & Marketing
09 March 2012 - 1:00AM
Marketwired
BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental
laser manufacturer and distributor, today announced that Vice
President, International, William E. Brown has been promoted to
Vice President, Sales & Marketing, effective immediately. In
this position, Brown will report directly to Federico Pignatelli,
Chairman and Chief Executive Officer.
Brown, 64, has more than 30 years of experience in global
medical/dental companies, with an emphasis in lasers. He joined the
marketing department of BIOLASE in 2002 and has held increasingly
responsible positions. As Vice President, International, he was
responsible for all international sales and distribution, including
the implementation of new sales and marketing strategies and
tactics across the Company's international dental markets, and has
been involved in business development activities since late
2010.
Pignatelli said, "Bill has been an integral part of our
management team and has played a critical role in the restructuring
and relaunch of BIOLASE. He has a proven track record, great
dedication and an in-depth understanding of the global dental laser
market and the needs of our customers and distributors. This
knowledge and expertise will be instrumental as we introduce new
market-leading products in our drive to become the Total Technology
Solution for the dental community."
Brown commented, "This is an exciting time at BIOLASE. We have
world-class products and the largest specialized sales force and
distribution network in the area. There are many marketing
opportunities for our patented technology in dentistry,
ophthalmology and other medical specialties. I believe we are well
positioned to take advantage of these opportunities and continue
the strong sales momentum from 2011 into this year."
Brown was a co-founder of Kreativ, Inc., an international high
tech dental equipment company, where he served from 1995 to 1999.
Following the acquisition in 1999 by Welch-Allyn, Inc., he served
as Director of New Product Development for Welch-Allyn Kreativ and
member of the Board of Directors until 2002. Prior to this, he
spent five years with HGM Medical Laser Systems, Inc., an
international medical laser manufacturer, as Vice President of
Sales and Marketing on a global basis.
Brown is on the Board of Directors of the World Congress of
Minimally Invasive Dentistry, Executive Director of the World
Clinical Laser Institute (WCLI), Fellow of the American Society for
Laser Medicine & Surgery (ASLMS), Member of SPIE, Biomedical
Optics Society, and the Academy of Laser Dentistry.
Brown holds a Bachelor's degree in Electrical Engineering from
the University of Alabama.
About BIOLASE Technology, Inc. BIOLASE
Technology, Inc., the World's leading Dental Laser Company, is a
medical technology company that develops, manufactures and markets
dental lasers and also distributes and markets dental imaging
equipment, products that are focused on technologies that advance
the practice of dentistry and medicine. The Company's laser
products incorporate 284 patented and patent pending technologies
designed to provide clinically superior performance with less pain
and faster recovery times. Its imaging products provide
cutting-edge technology at competitive prices to deliver the best
results for dentists and patients. BIOLASE's principal products are
dental laser systems that perform a broad range of dental
procedures, including cosmetic and complex surgical applications,
and a full line of dental imaging equipment. BIOLASE has sold more
than 19,000 lasers among 16,000 customers. Other products under
development address ophthalmology and other medical and consumer
markets.
For updates and information on laser and Waterlase dentistry,
find BIOLASE at http://www.biolase.com, Twitter at
http://twitter.com/GoWaterlase, and YouTube at
http://www.youtube.com/user/Rossca08.
This press release may contain forward-looking statements within
the meaning of safe harbor provided by the Securities Reform Act of
1995 that are based on the current expectations and estimates by
our management. These forward-looking statements can be identified
through the use of words such as "anticipates," "expects,"
"intends," "plans," "believes," "seeks," "estimates," "may,"
"will," and variations of these words or similar expressions.
Forward-looking statements are based on management's current,
preliminary expectations and are subject to risks, uncertainties
and other factors which may cause the Company's actual results to
differ materially from the statements contained herein, and are
described in the Company's reports it files with the Securities and
Exchange Commission, including its annual and quarterly reports. No
undue reliance should be placed on forward-looking statements. Such
information is subject to change, and we undertake no obligation to
update such statements.
For further information, please contact: Jill Bertotti of Allen
& Caron +1-949-474-4300
Biolase (NASDAQ:BLTI)
Historical Stock Chart
From May 2024 to Jun 2024
Biolase (NASDAQ:BLTI)
Historical Stock Chart
From Jun 2023 to Jun 2024